RxDoctor Payments DataLook up a doctor →

Andrew Westbrook, DO

Sports Medicine · Salina, KSNPI 1376072751

Payments from drug & device makers

$5,852in general payments, 2019–2025

Across 343 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$903
  • Amgen$665
  • Lilly USA, LLC$464
  • AstraZeneca$441
  • AbbVie$438
  • Novo Nordisk$343
  • plus $3K from 36 others

What the payments were for

  • Travel & lodging$50%
  • Food & beverage$5,847100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,852 in reported general payments places this provider in the 60th percentile of 56 sports medicine providers in Kansas.

See all sports medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$352,745
Medicare patients
423
Services billed
20,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$82,969
OzempicSemaglutide83$74,083
FarxigaDapagliflozin Propanediol77$65,829
JardianceEmpagliflozin55$57,112
Soliqua 100-33Insulin Glargine/Lixisenatide49$38,265
RybelsusSemaglutide15$23,951
Repatha SureclickEvolocumab17$14,478
MyrbetriqMirabegron19$12,786
MounjaroTirzepatide12$12,063
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,170
ShingrixVaricella-Zoster Ge/As01b/Pf37$8,316
Breo ElliptaFluticasone/Vilanterol15$5,662
AbrysvoRsv Vacc, Pref A And Pref B/Pf17$5,441
Novolog FlexpenInsulin Aspart12$2,494
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$2,229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$343$98,03498 claims
PfizerEliquis, Abrysvo$903$88,410146 claims
AstraZenecaFarxiga, Breztri Aerosphere$441$74,99988 claims
Boehringer IngelheimJardiance$30$57,11255 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$25$38,26549 claims
GSKShingrix, Breo Ellipta$167$13,97852 claims
Astellas Pharma US IncMyrbetriq$27$12,78619 claims
Lilly USA, LLCMounjaro$464$12,06312 claims
AbbVieSynthroid$438$1,80234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 56 sports medicine providers in Kansas.

Other sports medicine in Salina

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →